Education
About Us
Working with TipRanks
Follow Us
HKND - ETF AI Analysis
Top Page
Humankind US Stock ETF (HKND)
Rating:70Outperform
Price Target:
$39.00
Positive Factors
Strong Top Holdings
Several top positions, such as Alphabet and Intel, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Low Expense Ratio
The ETF charges a very low expense ratio, making it cost-effective compared to many other funds.
Sector Diversification
The ETF is spread across multiple sectors, with significant exposure to Health Care, Consumer Defensive, and Technology, reducing reliance on any single industry.
Negative Factors
Over-Concentration in U.S. Market
With nearly all assets focused on U.S. companies, the ETF lacks meaningful global diversification.
Underperforming Holdings
Some holdings, like Procter & Gamble, have shown weak year-to-date performance, which could drag on overall returns.
Heavy Reliance on Health Care Sector
The ETF's large allocation to Health Care (over 40%) increases vulnerability to sector-specific risks.
HKND vs. SPDR S&P 500 ETF (SPY)
AUM167.18M
RegionNorth America
Expense Ratio0.11%
Beta0.69
IssuerHumankind
Inception DateFeb 24, 2021
Dividend Yield1.67%
Asset ClassEquity
Index TrackedHumankind US Equity Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,138
30 Day Avg. Volume633
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
40.04Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering987
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HKND Summary
The Humankind US Stock ETF (HKND) is a fund that invests in a wide range of U.S. companies while focusing on socially responsible practices. It includes well-known companies like Apple and Microsoft, and covers sectors such as healthcare, technology, and consumer goods. This ETF is ideal for investors who want broad exposure to the U.S. stock market while supporting businesses that positively impact society. However, new investors should be aware that the ETF’s performance can fluctuate with the overall market, as it is tied to the U.S. equity index.
How much will it cost me?The Humankind US Stock ETF (HKND) has an expense ratio of 0.11%, meaning you’ll pay $1.10 per year for every $1,000 invested. This is lower than average because it’s passively managed, focusing on tracking a broad index rather than actively picking stocks.
What would affect this ETF?The Humankind US Stock ETF (HKND) could benefit from growth in the U.S. healthcare and technology sectors, which make up significant portions of its portfolio, especially if innovation and demand in these industries continue to rise. However, the ETF may face challenges if economic conditions worsen, such as higher interest rates or inflation, which could negatively impact consumer spending and corporate earnings across its diverse holdings. Additionally, changes in regulations or public sentiment around socially responsible investing could influence the fund's performance.
HKND Top 10 Holdings
The Humankind US Stock ETF leans heavily on healthcare, with names like Eli Lilly and AbbVie providing steady growth thanks to strong earnings and strategic investments. Intel has been a surprising bright spot, rising sharply on restructuring efforts, while Apple and Microsoft show mixed momentum, with solid fundamentals but slowing gains. Procter & Gamble, however, is dragging the fund with lagging performance amid macroeconomic challenges. Overall, the fund’s U.S.-centric portfolio balances tech innovation with healthcare stability, though its reliance on a few sectors may limit diversification.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Alphabet Class A | 5.10% | $8.48M | $3.34T | 60.25% | 80 Outperform | |
| Archer Daniels Midland | 3.07% | $5.11M | $28.17B | 9.86% | 63 Neutral | |
| Eli Lilly & Co | 3.06% | $5.08M | $969.28B | 37.40% | 76 Outperform | |
| Apple | 2.77% | $4.61M | $4.03T | 21.07% | 80 Outperform | |
| Bunge Global | 2.39% | $3.98M | $18.56B | 5.97% | 74 Outperform | |
| AbbVie | 2.35% | $3.90M | $410.67B | 40.83% | 62 Neutral | |
| Johnson & Johnson | 2.31% | $3.84M | $472.05B | 27.23% | 78 Outperform | |
| Intel | 2.21% | $3.68M | $169.43B | 45.87% | 61 Neutral | |
| Microsoft | 2.07% | $3.44M | $3.79T | 22.93% | 82 Outperform | |
| Procter & Gamble | 1.56% | $2.60M | $345.07B | -12.90% | 74 Outperform |
HKND Technical Analysis
Positive
―
Price Trends
34.87
Positive
33.94
Positive
32.63
Positive
Market Momentum
0.17
Negative
54.15
Neutral
66.67
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For HKND, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 35.34, equal to the 50-day MA of 34.87, and equal to the 200-day MA of 32.63, indicating a bullish trend. The MACD of 0.17 indicates Negative momentum. The RSI at 54.15 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HKND.
HKND Peer Comparison
Comparison Results
Performance Comparison
HKND
Humankind US Stock ETF
35.39
3.31
10.32%
SUSL
iShares ESG MSCI USA Leaders ETF
―
―
―
SYLD
Cambria Shareholder Yield ETF
―
―
―
PLDR
Putnam Sustainable Leaders ETF
―
―
―
ABFL
Fcf Us Quality Etf
―
―
―
PFM
Invesco Dividend Achievers ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents